Bibliometric analysis

Effect of vitamin d in adolescent girls with polycystic ovary syndrome (2005-2022)

https://doi.org/10.53730/ijhs.v6nS3.8004

Authors

  • Naaz Arora Associate Consultant Reproductive Medicine, Apollo cradle, Amritsar, Punjab, India
  • Meenu Arora Assistant Professor, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India

Keywords:

Asian girls, PCOS, anti-mullerian hormone, follicle stimulating hormone, human insulin

Abstract

The study's main objectives are to highlight and properly assess information about the work done in various dimensions suggesting the impact of Vitamin D deficiency on Polycystic ovary syndrome (PCOS) patients, to suggest the current state of knowledge, and to provide an exhaustive and unbiased assessment of the latest advances, as well as areas in need of improvement, concerns, and possible future research paths. Researchers used the programme R and the bibliometrix codes to conduct a descriptive bibliometric analysis and generate a matrix including all of the documents. The information was gathered from the PubMed database and the entire database between 2005 and 2022 was structured on the phrase "PCOS." Our final dataset consisted of 312 publications. We discovered a link between Vitamin D therapy and a variety of other probable PCOS treatments. The driving themes were found to be connected to "insulin resistance," "dietary supplements," and the "double blind method." In the current scenario research on Anti-mullerian hormone and follicle stimulating hormone investigations have gained a lot of traction. This paper gives a full grasp of the bibliometric parameters that link Vitamin D insufficiency to PCOS patients, and it can aid scientific research in this area.

Downloads

Download data is not yet available.

References

Carmina E, Lobo RA: Polycystic Ovary Syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999, 84:1897–9. 10.1210/jcem.84.6.5803

Hart R, Hickey M, Franks S: Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004, 18:671–83. 10.1016/j.bpobgyn.2004.05.001

Azin F, Khazali H: Phytotherapy of polycystic ovary syndrome: A review. Int J Reprod Biomed 2022, 20:13–20. 10.18502/ijrm.v20i1.10404

Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R: Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011, 7:219–31. 10.1038/nrendo.2010.217

Fauser BCJM: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19–25. 10.1016/j.fertnstert.2003.10.004

Farid NR, Diamanti-Kandarakis E: Diagnosis and management of polycystic ovary syndrome. 2009. 10.1007/978-0-387-09718-3

Fauser BCJM: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19–25. 10.1016/j.fertnstert.2003.10.004

Nautiyal H, Imam SS, Alshehri S, et al.: Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach. Biomedicines 2022, 10:540. 10.3390/biomedicines10030540

He C, Lin Z, Robb SW, Ezeamama AE: Serum vitamin d levels and polycystic ovary syndrome: A systematic review and meta-analysis. Nutrients 2015, 7:4555–77. 10.3390/nu7064555

Azhar A, Abid F, Rehman R: Polycystic ovary syndrome, subfertility and Vitamin D deficiency. J Coll Physicians Surg Pakistan 2020, 30:545–6. 10.29271/jcpsp.2020.5.545

Li Y, Wang J, Yang J, et al.: The correlation between vitamin D, glucose homeostasis and androgen level among polycystic ovary syndrome patients: a cross-sectional study. Gynecol Endocrinol 2021, 37:235–9. 10.1080/09513590.2020.1810228

Menichini D, Facchinetti F: Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review. Gynecol Endocrinol 2020, 36:1–5. 10.1080/09513590.2019.1625881

Li Y, Wang J, Yang J, et al.: The correlation between vitamin D, glucose homeostasis and androgen level among polycystic ovary syndrome patients: a cross-sectional study. Gynecol Endocrinol 2021, 37:235–9. 10.1080/09513590.2020.1810228

Holick MF: Vitamin D: The other steroid hormone for muscle function and strength. Menopause 2009, 16:1077–8. 10.1097/gme.0b013e3181bd9804

Hossein-Nezhad A, Holick MF: Vitamin D for health: A global perspective. In: Mayo Clinic Proceedings 2013. 720–55.10.1016/j.mayocp.2013.05.011

Chatterjee M: Vitamin D and genomic stability. Mutat Res Fundam Mol Mech Mutagen 2001, 475:69–87. 10.1016/S0027-5107(01)00080-X

Wojtusik J, Johnson PA: Vitamin D regulates anti-mullerian hormone expression in granulosa cells of the hen. Biol Reprod 2012, 86:. 10.1095/biolreprod.111.094110

Bakhshalizadeh S, Amidi F, Alleyassin A, Soleimani M, Shirazi R, Shabani Nashtaei M: Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome. Syst Biol Reprod Med 2017, 63:150–61. 10.1080/19396368.2017.1296046

Merhi Z: Vitamin D attenuates the effect of advanced glycation end products on anti-Mullerian hormone signaling. Mol Cell Endocrinol 2019, 479:87–92. 10.1016/j.mce.2018.09.004

Irani M, Merhi Z: Role of vitamin D in ovarian physiology and its implication in reproduction: A systematic review. Fertil Steril 2014, 102:. 10.1016/j.fertnstert.2014.04.046

Elkholy SS, Mostafa RA, Riad AA: Assessment of Vitamin D Levels in Women with Polycystic Ovarian Syndrome. Egypt J Hosp Med 2018, 70:594–600. 10.12816/0043811

Talaei A, Mohamadi M, Adgi Z: The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr 2013, 5:. 10.1186/1758-5996-5-8

Quélo I, Machuca I, Jurdic P: Identification of a vitamin D response element in the proximal promoter of the chicken carbonic anhydrase II gene. J Biol Chem 1998, 273:10638–46. 10.1074/jbc.273.17.10638

Ashraf A, Alvarez JA: Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010, 2010:. 10.1155/2010/351385

Glänzel W, Schoepflin U: A bibliometric study of reference literature in the sciences and social sciences. Inf Process Manag 1999, 35:31–44. 10.1016/S0306-4573(98)00028-4

Choudhri AF, Siddiqui A, Khan NR, Cohen HL: Understanding bibliometric parameters and analysis. Radiographics 2015, 35:736–46. 10.1148/rg.2015140036

Nash-Stewart CE, Kruesi LM, del Mar CB: Does bradford’s law of scattering predict the size of the literature in cochrane reviews? J Med Libr Assoc 2012, 100:135–8. 10.3163/1536-5050.100.2.013

Potter J: Mapping the literature of occupational therapy: An update jonathan potter. J Med Libr Assoc 2010, 98:235–42. 10.3163/1536-5050.98.3.012

Tennekes M: Tmap: Thematic maps in R. J Stat Softw 2018, 84:. 10.18637/jss.v084.i06

Published

28-05-2022

How to Cite

Arora, N., & Arora, M. (2022). Bibliometric analysis: Effect of vitamin d in adolescent girls with polycystic ovary syndrome (2005-2022). International Journal of Health Sciences, 6(S3), 8459–8476. https://doi.org/10.53730/ijhs.v6nS3.8004

Issue

Section

Peer Review Articles